# Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE

> **NCT07233642** · PHASE1 · RECRUITING · sponsor: **The Children's Hospital of Zhejiang University School of Medicine** · enrollment: 18 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **BIOLOGICAL:** CD19 CAR-T cells

## Key facts

- **NCT ID:** NCT07233642
- **Lead sponsor:** The Children's Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11
- **Primary completion:** 2026-05
- **Final completion:** 2028-09
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07233642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07233642, "Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07233642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*